Tumour-associated, membrane-bound human CA IX is upregulated in cancer cells, particularly in most clear cell renal cell carcinomas (ccRCCs) and contributes to hypoxic tumour pH/metabolic regulatory mechanisms. Here, CA9 is linked to neoplasm.